Close Menu

Over at TechCrunch, investor and entrepreneur James Altucher has nine points to consider to go about selling a startup company. First, he says, is to prepare a year ahead of time — he advises to start talking to potential buyer immediately and to keep them up to date as the company grows. Then he says to keep what he calls the 20:6:3:1 rule in mind: calling 20 companies that might be interested in a startup will lead to six meetings, then three serious offers, and one sold company.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.